Fatiabgen.Co.,Ltd

4 employees

Fatiabgen is a biopharmaceutical company that develops monoclonal antibody-based therapy for the treatment of infectious diseases.

Basic info

pharmaceutical manufacturing

ADC

Biotechnology

Lung Cancer

Biliary tract cancer

biomaker

Stem cell

healthcare

Liver cancer

pancreatic cancer

antibody drug

immunotoxins

Toxin Library

Organoid

Breast cancer

Pharmaceutical

nanobody

immunotoxin drug

Single domain antibody

Autoimmune Diseases

Cancer therapy

Medical

indication

Biopharma

peptide toxin

2020

Fatiabgen.Co.,Ltd raised undisclosed on January 1, 2023

Investors: UTC Investment Co.,Ltd.